10x Genomics (TXG) CFO Taich Adam Sells 17,166 Shares

What Happened
Taich Adam, Chief Financial Officer of 10x Genomics, sold 17,166 shares in an open‑market transaction on August 24, 2026. The weighted average sale price was $63.02 per share for total proceeds of approximately $1,081,853. The filing reports the sale code as S (sale).

Key Details

• Transaction date: 2026-08-24; filing date: 2026-08-26 (appears timely).
• Price(s): multiple trades at prices ranging from $63.0088 to $63.73; $63.02 is the weighted average.
• Shares sold: 17,166; proceeds ≈ $1,081,853.
• Shares owned after the transaction: not disclosed in this Form 4.
• Footnotes: F1 — sale was to cover tax withholding related to RSU vesting; F2 — multiple trade prices reported and the reporting person will provide breakdowns upon request.
• Transaction type: sell-to-cover for tax withholding (routine, not a new equity purchase).

Context
This was a sell-to-cover tied to the vesting of restricted stock units (RSUs), a common administrative transaction executives use to satisfy tax withholding obligations. Such sales are routine and do not necessarily reflect the insider’s view on the company’s prospects.